id	sid	tid	token	lemma	pos
dpc-4275	1	1	dermatology	dermatology	NOUN
dpc-4275	1	2	:	:	PUNCT
dpc-4275	1	3	practical	practical	ADJ
dpc-4275	1	4	and	and	CCONJ
dpc-4275	1	5	conceptual	conceptual	ADJ
dpc-4275	1	6	research	research	NOUN
dpc-4275	1	7	letter	letter	NOUN
dpc-4275	2	1	|	|	ADV
dpc-4275	2	2	dermatol	dermatol	ADJ
dpc-4275	2	3	pract	pract	NOUN
dpc-4275	2	4	concept	concept	NOUN
dpc-4275	2	5	.	.	PUNCT
dpc-4275	3	1	2024;14(4):e2024225	2024;14(4):e2024225	NUM
dpc-4275	3	2	1	1	NUM
dpc-4275	3	3	successful	successful	ADJ
dpc-4275	3	4	use	use	NOUN
dpc-4275	3	5	of	of	ADP
dpc-4275	3	6	photodynamic	photodynamic	ADJ
dpc-4275	3	7	therapy	therapy	NOUN
dpc-4275	3	8	for	for	ADP
dpc-4275	3	9	treatment	treatment	NOUN
dpc-4275	3	10	of	of	ADP
dpc-4275	3	11	palbociclib	palbociclib	NOUN
dpc-4275	3	12	-	-	PUNCT
dpc-4275	3	13	induced	induce	VERB
dpc-4275	3	14	periorificial	periorificial	ADJ
dpc-4275	3	15	dermatitis	dermatitis	NOUN
dpc-4275	3	16	davide	davide	PROPN
dpc-4275	3	17	fattore1	fattore1	PROPN
dpc-4275	3	18	,	,	PUNCT
dpc-4275	3	19	giuseppe	giuseppe	PROPN
dpc-4275	3	20	lauletta1	lauletta1	PROPN
dpc-4275	3	21	,	,	PUNCT
dpc-4275	3	22	matteo	matteo	PROPN
dpc-4275	3	23	megna1	megna1	PROPN
dpc-4275	3	24	,	,	PUNCT
dpc-4275	3	25	nello	nello	PROPN
dpc-4275	3	26	tommasino1	tommasino1	NOUN
dpc-4275	3	27	1	1	NUM
dpc-4275	3	28	section	section	NOUN
dpc-4275	3	29	of	of	ADP
dpc-4275	3	30	dermatology	dermatology	NOUN
dpc-4275	3	31	,	,	PUNCT
dpc-4275	3	32	department	department	NOUN
dpc-4275	3	33	of	of	ADP
dpc-4275	3	34	clinical	clinical	ADJ
dpc-4275	3	35	medicine	medicine	NOUN
dpc-4275	3	36	and	and	CCONJ
dpc-4275	3	37	surgery	surgery	NOUN
dpc-4275	3	38	,	,	PUNCT
dpc-4275	3	39	university	university	NOUN
dpc-4275	3	40	of	of	ADP
dpc-4275	3	41	naples	naples	PROPN
dpc-4275	3	42	federico	federico	PROPN
dpc-4275	3	43	ii	ii	PROPN
dpc-4275	3	44	,	,	PUNCT
dpc-4275	3	45	naples	naples	PROPN
dpc-4275	3	46	,	,	PUNCT
dpc-4275	3	47	italy	italy	PROPN
dpc-4275	3	48	key	key	ADJ
dpc-4275	3	49	words	word	NOUN
dpc-4275	3	50	:	:	PUNCT
dpc-4275	3	51	photodynamic	photodynamic	ADJ
dpc-4275	3	52	therapy	therapy	NOUN
dpc-4275	3	53	,	,	PUNCT
dpc-4275	3	54	periorificial	periorificial	NOUN
dpc-4275	3	55	,	,	PUNCT
dpc-4275	3	56	dermatitis	dermatitis	NOUN
dpc-4275	3	57	,	,	PUNCT
dpc-4275	3	58	palbociclib	palbociclib	ADJ
dpc-4275	3	59	citation	citation	NOUN
dpc-4275	3	60	:	:	PUNCT
dpc-4275	3	61	fattore	fattore	NOUN
dpc-4275	3	62	d	d	PROPN
dpc-4275	3	63	,	,	PUNCT
dpc-4275	3	64	lauletta	lauletta	NOUN
dpc-4275	3	65	g	g	NOUN
dpc-4275	3	66	,	,	PUNCT
dpc-4275	3	67	megna	megna	PROPN
dpc-4275	3	68	m	m	PROPN
dpc-4275	3	69	,	,	PUNCT
dpc-4275	3	70	tommasino	tommasino	PROPN
dpc-4275	3	71	n.	n.	NOUN
dpc-4275	3	72	successful	successful	ADJ
dpc-4275	3	73	use	use	NOUN
dpc-4275	3	74	of	of	ADP
dpc-4275	3	75	photodynamic	photodynamic	ADJ
dpc-4275	3	76	therapy	therapy	NOUN
dpc-4275	3	77	for	for	ADP
dpc-4275	3	78	treatment	treatment	NOUN
dpc-4275	3	79	of	of	ADP
dpc-4275	3	80	palbociclib	palbociclib	NOUN
dpc-4275	3	81	-	-	PUNCT
dpc-4275	3	82	induced	induce	VERB
dpc-4275	3	83	periorificial	periorificial	ADJ
dpc-4275	3	84	dermatitis	dermatitis	NOUN
dpc-4275	3	85	.	.	PUNCT
dpc-4275	4	1	dermatol	dermatol	NOUN
dpc-4275	4	2	pract	pract	PROPN
dpc-4275	4	3	concept	concept	NOUN
dpc-4275	4	4	.	.	PUNCT
dpc-4275	5	1	2024;14(4):e2024225	2024;14(4):e2024225	X
dpc-4275	5	2	.	.	PUNCT
dpc-4275	6	1	doi	doi	PROPN
dpc-4275	6	2	:	:	PUNCT
dpc-4275	6	3	https://doi.org/10.5826/dpc.1404a225	https://doi.org/10.5826/dpc.1404a225	PROPN
dpc-4275	6	4	accepted	accept	VERB
dpc-4275	6	5	:	:	PUNCT
dpc-4275	6	6	may	may	AUX
dpc-4275	6	7	19	19	NUM
dpc-4275	6	8	,	,	PUNCT
dpc-4275	6	9	2024	2024	NUM
dpc-4275	6	10	;	;	PUNCT
dpc-4275	6	11	published	publish	VERB
dpc-4275	6	12	:	:	PUNCT
dpc-4275	7	1	october	october	PROPN
dpc-4275	7	2	2024	2024	NUM
dpc-4275	7	3	copyright	copyright	NOUN
dpc-4275	7	4	:	:	PUNCT
dpc-4275	7	5	©	©	PROPN
dpc-4275	7	6	2024	2024	NUM
dpc-4275	7	7	fattore	fattore	NOUN
dpc-4275	7	8	et	et	PROPN
dpc-4275	7	9	al	al	PROPN
dpc-4275	7	10	.	.	PUNCT
dpc-4275	8	1	this	this	PRON
dpc-4275	8	2	is	be	AUX
dpc-4275	8	3	an	an	DET
dpc-4275	8	4	open	open	ADJ
dpc-4275	8	5	-	-	PUNCT
dpc-4275	8	6	access	access	NOUN
dpc-4275	8	7	article	article	NOUN
dpc-4275	8	8	distributed	distribute	VERB
dpc-4275	8	9	under	under	ADP
dpc-4275	8	10	the	the	DET
dpc-4275	8	11	terms	term	NOUN
dpc-4275	8	12	of	of	ADP
dpc-4275	8	13	the	the	DET
dpc-4275	8	14	creative	creative	ADJ
dpc-4275	8	15	commons	common	NOUN
dpc-4275	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4275	8	17	license	license	NOUN
dpc-4275	8	18	(	(	PUNCT
dpc-4275	8	19	by	by	ADP
dpc-4275	8	20	-	-	PUNCT
dpc-4275	8	21	nc-4.0	nc-4.0	NOUN
dpc-4275	8	22	)	)	PUNCT
dpc-4275	8	23	,	,	PUNCT
dpc-4275	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4275	8	25	,	,	PUNCT
dpc-4275	8	26	which	which	PRON
dpc-4275	8	27	permits	permit	VERB
dpc-4275	8	28	unrestricted	unrestricted	ADJ
dpc-4275	8	29	noncommercial	noncommercial	ADJ
dpc-4275	8	30	use	use	NOUN
dpc-4275	8	31	,	,	PUNCT
dpc-4275	8	32	distribution	distribution	NOUN
dpc-4275	8	33	,	,	PUNCT
dpc-4275	8	34	and	and	CCONJ
dpc-4275	8	35	reproduction	reproduction	NOUN
dpc-4275	8	36	in	in	ADP
dpc-4275	8	37	any	any	DET
dpc-4275	8	38	medium	medium	NOUN
dpc-4275	8	39	,	,	PUNCT
dpc-4275	8	40	provided	provide	VERB
dpc-4275	8	41	the	the	DET
dpc-4275	8	42	original	original	ADJ
dpc-4275	8	43	authors	author	NOUN
dpc-4275	8	44	and	and	CCONJ
dpc-4275	8	45	source	source	NOUN
dpc-4275	8	46	are	be	AUX
dpc-4275	8	47	credited	credit	VERB
dpc-4275	8	48	.	.	PUNCT
dpc-4275	9	1	funding	funding	NOUN
dpc-4275	9	2	:	:	PUNCT
dpc-4275	9	3	none	none	NOUN
dpc-4275	9	4	.	.	PUNCT
dpc-4275	10	1	competing	compete	VERB
dpc-4275	10	2	interests	interest	NOUN
dpc-4275	10	3	:	:	PUNCT
dpc-4275	10	4	none	none	NOUN
dpc-4275	10	5	.	.	PUNCT
dpc-4275	11	1	authorship	authorship	NOUN
dpc-4275	11	2	:	:	PUNCT
dpc-4275	11	3	all	all	DET
dpc-4275	11	4	authors	author	NOUN
dpc-4275	11	5	have	have	AUX
dpc-4275	11	6	contributed	contribute	VERB
dpc-4275	11	7	significantly	significantly	ADV
dpc-4275	11	8	to	to	ADP
dpc-4275	11	9	this	this	DET
dpc-4275	11	10	publication	publication	NOUN
dpc-4275	11	11	.	.	PUNCT
dpc-4275	12	1	corresponding	correspond	VERB
dpc-4275	12	2	author	author	NOUN
dpc-4275	12	3	:	:	PUNCT
dpc-4275	12	4	giuseppe	giuseppe	PROPN
dpc-4275	12	5	lauletta	lauletta	PROPN
dpc-4275	12	6	,	,	PUNCT
dpc-4275	12	7	section	section	NOUN
dpc-4275	12	8	of	of	ADP
dpc-4275	12	9	dermatology	dermatology	NOUN
dpc-4275	12	10	department	department	NOUN
dpc-4275	12	11	of	of	ADP
dpc-4275	12	12	clinical	clinical	ADJ
dpc-4275	12	13	medicine	medicine	NOUN
dpc-4275	12	14	and	and	CCONJ
dpc-4275	12	15	surgery	surgery	NOUN
dpc-4275	12	16	,	,	PUNCT
dpc-4275	12	17	university	university	NOUN
dpc-4275	12	18	of	of	ADP
dpc-4275	12	19	naples	naples	PROPN
dpc-4275	12	20	federico	federico	PROPN
dpc-4275	12	21	ii	ii	PROPN
dpc-4275	12	22	 	 	SPACE
dpc-4275	12	23	,	,	PUNCT
dpc-4275	12	24	via	via	ADP
dpc-4275	12	25	pansini	pansini	NOUN
dpc-4275	12	26	5	5	NUM
dpc-4275	12	27	,	,	PUNCT
dpc-4275	12	28	80131	80131	NUM
dpc-4275	12	29	napoli	napoli	PROPN
dpc-4275	12	30	,	,	PUNCT
dpc-4275	12	31	italy	italy	PROPN
dpc-4275	12	32	.	.	PUNCT
dpc-4275	13	1	tel	tel	ADP
dpc-4275	13	2	:	:	PUNCT
dpc-4275	13	3	+39	+39	PROPN
dpc-4275	13	4	081	081	NUM
dpc-4275	13	5	–	–	PUNCT
dpc-4275	13	6	7462457	7462457	NUM
dpc-4275	13	7	.	.	PUNCT
dpc-4275	14	1	fax	fax	NOUN
dpc-4275	14	2	:	:	PUNCT
dpc-4275	14	3	+39	+39	PROPN
dpc-4275	14	4	081	081	NUM
dpc-4275	14	5	–	–	PUNCT
dpc-4275	14	6	7462442	7462442	NUM
dpc-4275	14	7	.	.	PUNCT
dpc-4275	15	1	email	email	NOUN
dpc-4275	15	2	:	:	PUNCT
dpc-4275	16	1	giuseppelauletta@gmail.com	giuseppelauletta@gmail.com	X
dpc-4275	16	2	introduction	introduction	NOUN
dpc-4275	16	3	palbociclib	palbociclib	NOUN
dpc-4275	16	4	is	be	AUX
dpc-4275	16	5	an	an	DET
dpc-4275	16	6	oral	oral	ADJ
dpc-4275	16	7	small	small	ADJ
dpc-4275	16	8	molecule	molecule	NOUN
dpc-4275	16	9	inhibitor	inhibitor	NOUN
dpc-4275	16	10	of	of	ADP
dpc-4275	16	11	cyclin	cyclin	PROPN
dpc-4275	16	12	dependent	dependent	ADJ
dpc-4275	16	13	kinases	kinase	NOUN
dpc-4275	16	14	(	(	PUNCT
dpc-4275	16	15	cdk4	cdk4	NOUN
dpc-4275	16	16	and	and	CCONJ
dpc-4275	16	17	cdk6	cdk6	PROPN
dpc-4275	16	18	)	)	PUNCT
dpc-4275	16	19	,	,	PUNCT
dpc-4275	16	20	involved	involve	VERB
dpc-4275	16	21	in	in	ADP
dpc-4275	16	22	cell	cell	NOUN
dpc-4275	16	23	cycle	cycle	NOUN
dpc-4275	16	24	transition	transition	NOUN
dpc-4275	16	25	through	through	ADP
dpc-4275	16	26	their	their	PRON
dpc-4275	16	27	binding	binding	NOUN
dpc-4275	16	28	to	to	ADP
dpc-4275	16	29	cyclin	cyclin	NOUN
dpc-4275	16	30	-	-	PUNCT
dpc-4275	16	31	d[1	d[1	PROPN
dpc-4275	16	32	]	]	PUNCT
dpc-4275	16	33	.	.	PUNCT
dpc-4275	17	1	these	these	DET
dpc-4275	17	2	molecules	molecule	NOUN
dpc-4275	17	3	have	have	AUX
dpc-4275	17	4	become	become	VERB
dpc-4275	17	5	pharmacological	pharmacological	ADJ
dpc-4275	17	6	targets	target	NOUN
dpc-4275	17	7	,	,	PUNCT
dpc-4275	17	8	as	as	SCONJ
dpc-4275	17	9	their	their	PRON
dpc-4275	17	10	alterations	alteration	NOUN
dpc-4275	17	11	have	have	AUX
dpc-4275	17	12	been	be	AUX
dpc-4275	17	13	found	find	VERB
dpc-4275	17	14	in	in	ADP
dpc-4275	17	15	several	several	ADJ
dpc-4275	17	16	malignancies[1	malignancies[1	NOUN
dpc-4275	17	17	]	]	PUNCT
dpc-4275	17	18	.	.	PUNCT
dpc-4275	18	1	in	in	ADP
dpc-4275	18	2	particular	particular	ADJ
dpc-4275	18	3	,	,	PUNCT
dpc-4275	18	4	palbociclib	palbociclib	NOUN
dpc-4275	18	5	is	be	AUX
dpc-4275	18	6	indicated	indicate	VERB
dpc-4275	18	7	for	for	ADP
dpc-4275	18	8	the	the	DET
dpc-4275	18	9	treatment	treatment	NOUN
dpc-4275	18	10	of	of	ADP
dpc-4275	18	11	locally	locally	ADV
dpc-4275	18	12	advanced	advanced	ADJ
dpc-4275	18	13	or	or	CCONJ
dpc-4275	18	14	metastatic	metastatic	ADJ
dpc-4275	18	15	hormone	hormone	NOUN
dpc-4275	18	16	receptor	receptor	NOUN
dpc-4275	18	17	(	(	PUNCT
dpc-4275	18	18	hr)-positive	hr)-positive	ADJ
dpc-4275	18	19	and	and	CCONJ
dpc-4275	18	20	human	human	ADJ
dpc-4275	18	21	epidermal	epidermal	ADJ
dpc-4275	18	22	growth	growth	NOUN
dpc-4275	18	23	factor	factor	NOUN
dpc-4275	18	24	receptor	receptor	NOUN
dpc-4275	18	25	(	(	PUNCT
dpc-4275	18	26	her	her	NOUN
dpc-4275	18	27	)	)	PUNCT
dpc-4275	18	28	2	2	NUM
dpc-4275	18	29	-	-	PUNCT
dpc-4275	18	30	negative	negative	ADJ
dpc-4275	18	31	breast	breast	NOUN
dpc-4275	18	32	cancer	cancer	NOUN
dpc-4275	18	33	in	in	ADP
dpc-4275	18	34	combination	combination	NOUN
dpc-4275	18	35	with	with	ADP
dpc-4275	18	36	an	an	DET
dpc-4275	18	37	aromatase	aromatase	NOUN
dpc-4275	18	38	inhibitor[1	inhibitor[1	PROPN
dpc-4275	18	39	]	]	PUNCT
dpc-4275	18	40	.	.	PUNCT
dpc-4275	19	1	hematological	hematological	ADJ
dpc-4275	19	2	toxicity	toxicity	NOUN
dpc-4275	19	3	,	,	PUNCT
dpc-4275	19	4	with	with	ADP
dpc-4275	19	5	leukopenia	leukopenia	NOUN
dpc-4275	19	6	and	and	CCONJ
dpc-4275	19	7	anemia	anemia	NOUN
dpc-4275	19	8	,	,	PUNCT
dpc-4275	19	9	is	be	AUX
dpc-4275	19	10	the	the	DET
dpc-4275	19	11	most	most	ADV
dpc-4275	19	12	frequently	frequently	ADV
dpc-4275	19	13	reported	report	VERB
dpc-4275	19	14	adverse	adverse	ADJ
dpc-4275	19	15	effects	effect	NOUN
dpc-4275	19	16	(	(	PUNCT
dpc-4275	19	17	aes)[1	aes)[1	PROPN
dpc-4275	19	18	]	]	PUNCT
dpc-4275	19	19	.	.	PUNCT
dpc-4275	20	1	cutaneous	cutaneous	ADJ
dpc-4275	20	2	aes	aes	PROPN
dpc-4275	20	3	are	be	AUX
dpc-4275	20	4	also	also	ADV
dpc-4275	20	5	common	common	ADJ
dpc-4275	20	6	,	,	PUNCT
dpc-4275	20	7	in	in	ADP
dpc-4275	20	8	particular	particular	ADJ
dpc-4275	20	9	itching	itching	NOUN
dpc-4275	20	10	,	,	PUNCT
dpc-4275	20	11	alopecia	alopecia	NOUN
dpc-4275	20	12	,	,	PUNCT
dpc-4275	20	13	and	and	CCONJ
dpc-4275	20	14	eczematous	eczematous	ADJ
dpc-4275	20	15	rash[1	rash[1	NOUN
dpc-4275	20	16	]	]	PUNCT
dpc-4275	20	17	.	.	PUNCT
dpc-4275	21	1	the	the	DET
dpc-4275	21	2	presence	presence	NOUN
dpc-4275	21	3	of	of	ADP
dpc-4275	21	4	skin	skin	NOUN
dpc-4275	21	5	toxicity	toxicity	NOUN
dpc-4275	21	6	during	during	ADP
dpc-4275	21	7	cancer	cancer	NOUN
dpc-4275	21	8	therapy	therapy	NOUN
dpc-4275	21	9	can	can	AUX
dpc-4275	21	10	cause	cause	VERB
dpc-4275	21	11	discontinuation	discontinuation	NOUN
dpc-4275	21	12	of	of	ADP
dpc-4275	21	13	therapy	therapy	NOUN
dpc-4275	21	14	,	,	PUNCT
dpc-4275	21	15	with	with	ADP
dpc-4275	21	16	severe	severe	ADJ
dpc-4275	21	17	impact	impact	NOUN
dpc-4275	21	18	on	on	ADP
dpc-4275	21	19	quality	quality	NOUN
dpc-4275	21	20	of	of	ADP
dpc-4275	21	21	life	life	NOUN
dpc-4275	21	22	and	and	CCONJ
dpc-4275	21	23	treatment	treatment	NOUN
dpc-4275	21	24	success[2	success[2	PROPN
dpc-4275	21	25	]	]	PUNCT
dpc-4275	21	26	.	.	PUNCT
dpc-4275	22	1	we	we	PRON
dpc-4275	22	2	present	present	VERB
dpc-4275	22	3	a	a	DET
dpc-4275	22	4	case	case	NOUN
dpc-4275	22	5	of	of	ADP
dpc-4275	22	6	palbociclib	palbociclib	NOUN
dpc-4275	22	7	-	-	PUNCT
dpc-4275	22	8	induced	induce	VERB
dpc-4275	22	9	periorificial	periorificial	ADJ
dpc-4275	22	10	dermatitis	dermatitis	NOUN
dpc-4275	22	11	(	(	PUNCT
dpc-4275	22	12	pod	pod	NOUN
dpc-4275	22	13	)	)	PUNCT
dpc-4275	22	14	successfully	successfully	ADV
dpc-4275	22	15	treated	treat	VERB
dpc-4275	22	16	with	with	ADP
dpc-4275	22	17	photodynamic	photodynamic	ADJ
dpc-4275	22	18	therapy	therapy	NOUN
dpc-4275	22	19	(	(	PUNCT
dpc-4275	22	20	pdt	pdt	PROPN
dpc-4275	22	21	)	)	PUNCT
dpc-4275	22	22	.	.	PUNCT
dpc-4275	23	1	case	case	NOUN
dpc-4275	23	2	presentation	presentation	NOUN
dpc-4275	23	3	a	a	DET
dpc-4275	23	4	50	50	NUM
dpc-4275	23	5	-	-	PUNCT
dpc-4275	23	6	year	year	NOUN
dpc-4275	23	7	-	-	PUNCT
dpc-4275	23	8	old	old	ADJ
dpc-4275	23	9	breast	breast	NOUN
dpc-4275	23	10	cancer	cancer	NOUN
dpc-4275	23	11	patient	patient	NOUN
dpc-4275	23	12	with	with	ADP
dpc-4275	23	13	lung	lung	NOUN
dpc-4275	23	14	metastases	metastasis	NOUN
dpc-4275	23	15	in	in	ADP
dpc-4275	23	16	treatment	treatment	NOUN
dpc-4275	23	17	with	with	ADP
dpc-4275	23	18	palbociclib	palbociclib	NOUN
dpc-4275	23	19	and	and	CCONJ
dpc-4275	23	20	letrozole	letrozole	NOUN
dpc-4275	23	21	came	come	VERB
dpc-4275	23	22	to	to	ADP
dpc-4275	23	23	our	our	PRON
dpc-4275	23	24	attention	attention	NOUN
dpc-4275	23	25	for	for	ADP
dpc-4275	23	26	diffuse	diffuse	ADJ
dpc-4275	23	27	papules	papule	NOUN
dpc-4275	23	28	and	and	CCONJ
dpc-4275	23	29	rare	rare	ADJ
dpc-4275	23	30	pustules	pustule	NOUN
dpc-4275	23	31	around	around	ADP
dpc-4275	23	32	the	the	DET
dpc-4275	23	33	mouth	mouth	NOUN
dpc-4275	23	34	,	,	PUNCT
dpc-4275	23	35	the	the	DET
dpc-4275	23	36	nose	nose	NOUN
dpc-4275	23	37	,	,	PUNCT
dpc-4275	23	38	and	and	CCONJ
dpc-4275	23	39	the	the	DET
dpc-4275	23	40	orbits	orbit	NOUN
dpc-4275	23	41	,	,	PUNCT
dpc-4275	23	42	on	on	ADP
dpc-4275	23	43	an	an	DET
dpc-4275	23	44	erythematous	erythematous	ADJ
dpc-4275	23	45	background	background	NOUN
dpc-4275	23	46	(	(	PUNCT
dpc-4275	23	47	figure	figure	NOUN
dpc-4275	23	48	1	1	NUM
dpc-4275	23	49	)	)	PUNCT
dpc-4275	23	50	,	,	PUNCT
dpc-4275	23	51	with	with	ADP
dpc-4275	23	52	itching	itching	NOUN
dpc-4275	23	53	and	and	CCONJ
dpc-4275	23	54	burning	burning	NOUN
dpc-4275	23	55	and	and	CCONJ
dpc-4275	23	56	a	a	DET
dpc-4275	23	57	significant	significant	ADJ
dpc-4275	23	58	negative	negative	ADJ
dpc-4275	23	59	impact	impact	NOUN
dpc-4275	23	60	on	on	ADP
dpc-4275	23	61	quality	quality	NOUN
dpc-4275	23	62	of	of	ADP
dpc-4275	23	63	life	life	NOUN
dpc-4275	23	64	.	.	PUNCT
dpc-4275	24	1	on	on	ADP
dpc-4275	24	2	palpation	palpation	NOUN
dpc-4275	24	3	the	the	DET
dpc-4275	24	4	patient	patient	NOUN
dpc-4275	24	5	reported	report	VERB
dpc-4275	24	6	pain	pain	NOUN
dpc-4275	24	7	and	and	CCONJ
dpc-4275	24	8	severe	severe	ADJ
dpc-4275	24	9	burning	burning	NOUN
dpc-4275	24	10	.	.	PUNCT
dpc-4275	25	1	the	the	DET
dpc-4275	25	2	diagnosis	diagnosis	NOUN
dpc-4275	25	3	of	of	ADP
dpc-4275	25	4	pod	pod	NOUN
dpc-4275	25	5	was	be	AUX
dpc-4275	25	6	confirmed	confirm	VERB
dpc-4275	25	7	by	by	ADP
dpc-4275	25	8	a	a	DET
dpc-4275	25	9	3	3	NUM
dpc-4275	25	10	-	-	PUNCT
dpc-4275	25	11	mm	mm	NOUN
dpc-4275	25	12	-	-	PUNCT
dpc-4275	25	13	diameter	diameter	NOUN
dpc-4275	25	14	punch	punch	NOUN
dpc-4275	25	15	skin	skin	NOUN
dpc-4275	25	16	biopsy	biopsy	NOUN
dpc-4275	25	17	.	.	PUNCT
dpc-4275	26	1	oral	oral	ADJ
dpc-4275	26	2	doxycycline	doxycycline	NOUN
dpc-4275	26	3	and	and	CCONJ
dpc-4275	26	4	topical	topical	ADJ
dpc-4275	26	5	antibiotics	antibiotic	NOUN
dpc-4275	26	6	were	be	AUX
dpc-4275	26	7	started	start	VERB
dpc-4275	26	8	,	,	PUNCT
dpc-4275	26	9	but	but	CCONJ
dpc-4275	26	10	no	no	DET
dpc-4275	26	11	improvement	improvement	NOUN
dpc-4275	26	12	was	be	AUX
dpc-4275	26	13	observed	observe	VERB
dpc-4275	26	14	.	.	PUNCT
dpc-4275	27	1	therefore	therefore	ADV
dpc-4275	27	2	,	,	PUNCT
dpc-4275	27	3	the	the	DET
dpc-4275	27	4	treatment	treatment	NOUN
dpc-4275	27	5	was	be	AUX
dpc-4275	27	6	switched	switch	VERB
dpc-4275	27	7	to	to	PART
dpc-4275	27	8	pdt	pdt	VERB
dpc-4275	27	9	with	with	ADP
dpc-4275	27	10	topical	topical	ADJ
dpc-4275	27	11	methyl	methyl	NOUN
dpc-4275	27	12	5	5	NUM
dpc-4275	27	13	-	-	PUNCT
dpc-4275	27	14	aminolevulinic	aminolevulinic	ADJ
dpc-4275	27	15	acid	acid	NOUN
dpc-4275	27	16	(	(	PUNCT
dpc-4275	27	17	mal	mal	ADJ
dpc-4275	27	18	)	)	PUNCT
dpc-4275	27	19	once	once	ADV
dpc-4275	27	20	a	a	DET
dpc-4275	27	21	month	month	NOUN
dpc-4275	27	22	at	at	ADP
dpc-4275	27	23	37	37	NUM
dpc-4275	27	24	j	j	PROPN
dpc-4275	27	25	/	/	SYM
dpc-4275	27	26	cm2	cm2	PROPN
dpc-4275	27	27	.	.	PROPN
dpc-4275	28	1	we	we	PRON
dpc-4275	28	2	observed	observe	VERB
dpc-4275	28	3	a	a	DET
dpc-4275	28	4	meaningful	meaningful	ADJ
dpc-4275	28	5	reduction	reduction	NOUN
dpc-4275	28	6	in	in	ADP
dpc-4275	28	7	the	the	DET
dpc-4275	28	8	number	number	NOUN
dpc-4275	28	9	of	of	ADP
dpc-4275	28	10	papules	papule	NOUN
dpc-4275	28	11	and	and	CCONJ
dpc-4275	28	12	in	in	ADP
dpc-4275	28	13	the	the	DET
dpc-4275	28	14	extent	extent	NOUN
dpc-4275	28	15	of	of	ADP
dpc-4275	28	16	the	the	DET
dpc-4275	28	17	erythematous	erythematous	ADJ
dpc-4275	28	18	area	area	NOUN
dpc-4275	28	19	from	from	ADP
dpc-4275	28	20	the	the	DET
dpc-4275	28	21	first	first	ADJ
dpc-4275	28	22	session	session	NOUN
dpc-4275	28	23	,	,	PUNCT
dpc-4275	28	24	with	with	ADP
dpc-4275	28	25	almost	almost	ADV
dpc-4275	28	26	complete	complete	ADJ
dpc-4275	28	27	clearance	clearance	NOUN
dpc-4275	28	28	at	at	ADP
dpc-4275	28	29	the	the	DET
dpc-4275	28	30	third	third	ADJ
dpc-4275	28	31	session	session	NOUN
dpc-4275	28	32	(	(	PUNCT
dpc-4275	28	33	figure	figure	NOUN
dpc-4275	28	34	2	2	NUM
dpc-4275	28	35	)	)	PUNCT
dpc-4275	28	36	.	.	PUNCT
dpc-4275	29	1	no	no	DET
dpc-4275	29	2	aes	aes	NOUN
dpc-4275	29	3	occurred	occur	VERB
dpc-4275	29	4	,	,	PUNCT
dpc-4275	29	5	and	and	CCONJ
dpc-4275	29	6	no	no	DET
dpc-4275	29	7	recurrence	recurrence	NOUN
dpc-4275	29	8	was	be	AUX
dpc-4275	29	9	reported	report	VERB
dpc-4275	29	10	during	during	ADP
dpc-4275	29	11	the	the	DET
dpc-4275	29	12	following	follow	VERB
dpc-4275	29	13	three	three	NUM
dpc-4275	29	14	monthly	monthly	ADJ
dpc-4275	29	15	visits	visit	NOUN
dpc-4275	29	16	.	.	PUNCT
dpc-4275	30	1	2	2	NUM
dpc-4275	30	2	research	research	NOUN
dpc-4275	30	3	letter	letter	NOUN
dpc-4275	30	4	|	|	ADV
dpc-4275	30	5	dermatol	dermatol	ADJ
dpc-4275	30	6	pract	pract	NOUN
dpc-4275	30	7	concept	concept	NOUN
dpc-4275	30	8	.	.	PUNCT
dpc-4275	31	1	2024;14(4):e2024225	2024;14(4):e2024225	NUM
dpc-4275	31	2	discussion	discussion	NOUN
dpc-4275	31	3	pod	pod	NOUN
dpc-4275	31	4	is	be	AUX
dpc-4275	31	5	an	an	DET
dpc-4275	31	6	erythematous	erythematous	ADJ
dpc-4275	31	7	papulopustular	papulopustular	ADJ
dpc-4275	31	8	rash	rash	NOUN
dpc-4275	31	9	of	of	ADP
dpc-4275	31	10	the	the	DET
dpc-4275	31	11	skin	skin	NOUN
dpc-4275	31	12	around	around	ADP
dpc-4275	31	13	the	the	DET
dpc-4275	31	14	mouth	mouth	NOUN
dpc-4275	31	15	,	,	PUNCT
dpc-4275	31	16	nose	nose	NOUN
dpc-4275	31	17	,	,	PUNCT
dpc-4275	31	18	and	and	CCONJ
dpc-4275	31	19	orbits[3	orbits[3	NOUN
dpc-4275	31	20	]	]	X
dpc-4275	31	21	.	.	PUNCT
dpc-4275	32	1	the	the	DET
dpc-4275	32	2	most	most	ADV
dpc-4275	32	3	common	common	ADJ
dpc-4275	32	4	symptoms	symptom	NOUN
dpc-4275	32	5	are	be	AUX
dpc-4275	32	6	itching	itch	VERB
dpc-4275	32	7	and	and	CCONJ
dpc-4275	32	8	burning[3	burning[3	NUM
dpc-4275	32	9	]	]	PUNCT
dpc-4275	32	10	.	.	PUNCT
dpc-4275	33	1	due	due	ADP
dpc-4275	33	2	to	to	ADP
dpc-4275	33	3	the	the	DET
dpc-4275	33	4	similar	similar	ADJ
dpc-4275	33	5	distribution	distribution	NOUN
dpc-4275	33	6	of	of	ADP
dpc-4275	33	7	manifestations	manifestation	NOUN
dpc-4275	33	8	,	,	PUNCT
dpc-4275	33	9	pod	pod	NOUN
dpc-4275	33	10	must	must	AUX
dpc-4275	33	11	be	be	AUX
dpc-4275	33	12	differentiated	differentiate	VERB
dpc-4275	33	13	from	from	ADP
dpc-4275	33	14	acne	acne	NOUN
dpc-4275	33	15	vulgaris	vulgaris	NOUN
dpc-4275	33	16	,	,	PUNCT
dpc-4275	33	17	rosacea	rosacea	NOUN
dpc-4275	33	18	,	,	PUNCT
dpc-4275	33	19	and	and	CCONJ
dpc-4275	33	20	lupus	lupus	NOUN
dpc-4275	33	21	disseminates	disseminate	NOUN
dpc-4275	33	22	faciei[3	faciei[3	NOUN
dpc-4275	33	23	]	]	PUNCT
dpc-4275	33	24	.	.	PUNCT
dpc-4275	34	1	first	first	ADJ
dpc-4275	34	2	-	-	PUNCT
dpc-4275	34	3	line	line	NOUN
dpc-4275	34	4	therapy	therapy	NOUN
dpc-4275	34	5	includes	include	VERB
dpc-4275	34	6	topical	topical	ADJ
dpc-4275	34	7	antibiotics	antibiotic	NOUN
dpc-4275	34	8	such	such	ADJ
dpc-4275	34	9	as	as	ADP
dpc-4275	34	10	metronidazole	metronidazole	NOUN
dpc-4275	34	11	,	,	PUNCT
dpc-4275	34	12	erythromycin	erythromycin	NOUN
dpc-4275	34	13	,	,	PUNCT
dpc-4275	34	14	or	or	CCONJ
dpc-4275	34	15	clindamycin	clindamycin	NOUN
dpc-4275	34	16	,	,	PUNCT
dpc-4275	34	17	used	use	VERB
dpc-4275	34	18	for	for	ADP
dpc-4275	34	19	their	their	PRON
dpc-4275	34	20	anti	anti	ADJ
dpc-4275	34	21	-	-	ADJ
dpc-4275	34	22	inflammatory	inflammatory	ADJ
dpc-4275	34	23	properties[3	properties[3	ADJ
dpc-4275	34	24	]	]	PUNCT
dpc-4275	34	25	.	.	PUNCT
dpc-4275	35	1	other	other	ADJ
dpc-4275	35	2	local	local	ADJ
dpc-4275	35	3	treatments	treatment	NOUN
dpc-4275	35	4	include	include	VERB
dpc-4275	35	5	calcineurin	calcineurin	NOUN
dpc-4275	35	6	inhibitors[3	inhibitors[3	PROPN
dpc-4275	35	7	]	]	PUNCT
dpc-4275	35	8	.	.	PUNCT
dpc-4275	36	1	in	in	ADP
dpc-4275	36	2	more	more	ADV
dpc-4275	36	3	severe	severe	ADJ
dpc-4275	36	4	cases	case	NOUN
dpc-4275	36	5	,	,	PUNCT
dpc-4275	36	6	oral	oral	ADJ
dpc-4275	36	7	tetracyclines	tetracycline	NOUN
dpc-4275	36	8	or	or	CCONJ
dpc-4275	36	9	isotretinoin	isotretinoin	PROPN
dpc-4275	36	10	are	be	AUX
dpc-4275	36	11	indicated[3	indicated[3	ADJ
dpc-4275	36	12	]	]	PUNCT
dpc-4275	36	13	.	.	PUNCT
dpc-4275	37	1	in	in	ADP
dpc-4275	37	2	their	their	PRON
dpc-4275	37	3	study	study	NOUN
dpc-4275	37	4	on	on	ADP
dpc-4275	37	5	skin	skin	NOUN
dpc-4275	37	6	aes	aes	PROPN
dpc-4275	37	7	during	during	ADP
dpc-4275	37	8	palbociclib	palbociclib	PROPN
dpc-4275	37	9	therapy	therapy	NOUN
dpc-4275	37	10	,	,	PUNCT
dpc-4275	37	11	amigo	amigo	PROPN
dpc-4275	37	12	et	et	PROPN
dpc-4275	37	13	al	al	PROPN
dpc-4275	37	14	.	.	PROPN
dpc-4275	37	15	described	describe	VERB
dpc-4275	37	16	the	the	DET
dpc-4275	37	17	appearance	appearance	NOUN
dpc-4275	37	18	of	of	ADP
dpc-4275	37	19	pod	pod	NOUN
dpc-4275	37	20	in	in	ADP
dpc-4275	37	21	a	a	DET
dpc-4275	37	22	65	65	NUM
dpc-4275	37	23	-	-	NUM
dpc-4275	37	24	yearold	yearold	NUM
dpc-4275	37	25	patient	patient	NOUN
dpc-4275	37	26	after	after	ADP
dpc-4275	37	27	10	10	NUM
dpc-4275	37	28	months	month	NOUN
dpc-4275	37	29	of	of	ADP
dpc-4275	37	30	therapy	therapy	NOUN
dpc-4275	37	31	,	,	PUNCT
dpc-4275	37	32	successfully	successfully	ADV
dpc-4275	37	33	treated	treat	VERB
dpc-4275	37	34	with	with	ADP
dpc-4275	37	35	topical	topical	ADJ
dpc-4275	37	36	metronidazole	metronidazole	NOUN
dpc-4275	38	1	[	[	X
dpc-4275	38	2	4	4	NUM
dpc-4275	38	3	]	]	PUNCT
dpc-4275	38	4	.	.	PUNCT
dpc-4275	39	1	another	another	DET
dpc-4275	39	2	treatment	treatment	NOUN
dpc-4275	39	3	option	option	NOUN
dpc-4275	39	4	is	be	AUX
dpc-4275	39	5	pdt	pdt	PROPN
dpc-4275	39	6	.	.	PUNCT
dpc-4275	40	1	richey	richey	PROPN
dpc-4275	40	2	and	and	CCONJ
dpc-4275	40	3	hopson	hopson	PROPN
dpc-4275	40	4	treated	treat	VERB
dpc-4275	40	5	21	21	NUM
dpc-4275	40	6	patients	patient	NOUN
dpc-4275	40	7	with	with	ADP
dpc-4275	40	8	pod	pod	NOUN
dpc-4275	40	9	on	on	ADP
dpc-4275	40	10	half	half	DET
dpc-4275	40	11	the	the	DET
dpc-4275	40	12	face	face	NOUN
dpc-4275	40	13	with	with	ADP
dpc-4275	40	14	topical	topical	ADJ
dpc-4275	40	15	clindamycin	clindamycin	NOUN
dpc-4275	40	16	and	and	CCONJ
dpc-4275	40	17	the	the	DET
dpc-4275	40	18	other	other	ADJ
dpc-4275	40	19	half	half	NOUN
dpc-4275	40	20	with	with	ADP
dpc-4275	40	21	pdt	pdt	PROPN
dpc-4275	40	22	.	.	PUNCT
dpc-4275	41	1	among	among	ADP
dpc-4275	41	2	the	the	DET
dpc-4275	41	3	14	14	NUM
dpc-4275	41	4	patients	patient	NOUN
dpc-4275	41	5	who	who	PRON
dpc-4275	41	6	completed	complete	VERB
dpc-4275	41	7	the	the	DET
dpc-4275	41	8	study	study	NOUN
dpc-4275	41	9	,	,	PUNCT
dpc-4275	41	10	an	an	DET
dpc-4275	41	11	average	average	ADJ
dpc-4275	41	12	clearance	clearance	NOUN
dpc-4275	41	13	of	of	ADP
dpc-4275	41	14	92	92	NUM
dpc-4275	41	15	%	%	NOUN
dpc-4275	41	16	on	on	ADP
dpc-4275	41	17	the	the	DET
dpc-4275	41	18	half	half	ADJ
dpc-4275	41	19	-	-	PUNCT
dpc-4275	41	20	face	face	NOUN
dpc-4275	41	21	treated	treat	VERB
dpc-4275	41	22	with	with	ADP
dpc-4275	41	23	pdt	pdt	PROPN
dpc-4275	41	24	was	be	AUX
dpc-4275	41	25	observed	observe	VERB
dpc-4275	41	26	,	,	PUNCT
dpc-4275	41	27	compared	compare	VERB
dpc-4275	41	28	to	to	ADP
dpc-4275	41	29	81	81	NUM
dpc-4275	41	30	%	%	NOUN
dpc-4275	41	31	of	of	ADP
dpc-4275	41	32	the	the	DET
dpc-4275	41	33	half	half	NOUN
dpc-4275	41	34	treated	treat	VERB
dpc-4275	41	35	with	with	ADP
dpc-4275	41	36	topical	topical	ADJ
dpc-4275	41	37	clindamycin	clindamycin	NOUN
dpc-4275	41	38	(	(	PUNCT
dpc-4275	41	39	p=0.0227)[5	p=0.0227)[5	NOUN
dpc-4275	41	40	]	]	PUNCT
dpc-4275	41	41	.	.	PUNCT
dpc-4275	42	1	since	since	SCONJ
dpc-4275	42	2	conventional	conventional	ADJ
dpc-4275	42	3	therapies	therapy	NOUN
dpc-4275	42	4	had	have	AUX
dpc-4275	42	5	failed	fail	VERB
dpc-4275	42	6	on	on	ADP
dpc-4275	42	7	our	our	PRON
dpc-4275	42	8	patient	patient	NOUN
dpc-4275	42	9	,	,	PUNCT
dpc-4275	42	10	mal	mal	ADJ
dpc-4275	42	11	-	-	PUNCT
dpc-4275	42	12	pdt	pdt	PROPN
dpc-4275	42	13	was	be	AUX
dpc-4275	42	14	initiated	initiate	VERB
dpc-4275	42	15	,	,	PUNCT
dpc-4275	42	16	with	with	ADP
dpc-4275	42	17	the	the	DET
dpc-4275	42	18	excellent	excellent	ADJ
dpc-4275	42	19	results	result	NOUN
dpc-4275	42	20	described	describe	VERB
dpc-4275	42	21	above	above	ADV
dpc-4275	42	22	.	.	PUNCT
dpc-4275	43	1	conclusion	conclusion	NOUN
dpc-4275	43	2	we	we	PRON
dpc-4275	43	3	have	have	AUX
dpc-4275	43	4	reported	report	VERB
dpc-4275	43	5	this	this	DET
dpc-4275	43	6	case	case	NOUN
dpc-4275	43	7	because	because	SCONJ
dpc-4275	43	8	the	the	DET
dpc-4275	43	9	palbociclib	palbociclib	NOUN
dpc-4275	43	10	-	-	PUNCT
dpc-4275	43	11	induced	induce	VERB
dpc-4275	43	12	pod	pod	NOUN
dpc-4275	43	13	was	be	AUX
dpc-4275	43	14	successfully	successfully	ADV
dpc-4275	43	15	treated	treat	VERB
dpc-4275	43	16	with	with	ADP
dpc-4275	43	17	pdt	pdt	PROPN
dpc-4275	43	18	,	,	PUNCT
dpc-4275	43	19	a	a	DET
dpc-4275	43	20	therapy	therapy	NOUN
dpc-4275	43	21	that	that	PRON
dpc-4275	43	22	has	have	VERB
dpc-4275	43	23	no	no	DET
dpc-4275	43	24	systemic	systemic	ADJ
dpc-4275	43	25	aes	aes	PROPN
dpc-4275	43	26	,	,	PUNCT
dpc-4275	43	27	which	which	PRON
dpc-4275	43	28	is	be	AUX
dpc-4275	43	29	ideal	ideal	ADJ
dpc-4275	43	30	for	for	ADP
dpc-4275	43	31	cancer	cancer	NOUN
dpc-4275	43	32	patients	patient	NOUN
dpc-4275	43	33	and	and	CCONJ
dpc-4275	43	34	allows	allow	VERB
dpc-4275	43	35	them	they	PRON
dpc-4275	43	36	to	to	PART
dpc-4275	43	37	continue	continue	VERB
dpc-4275	43	38	their	their	PRON
dpc-4275	43	39	cancer	cancer	NOUN
dpc-4275	43	40	therapy	therapy	NOUN
dpc-4275	43	41	.	.	PUNCT
dpc-4275	44	1	references	reference	NOUN
dpc-4275	44	2	1	1	NUM
dpc-4275	44	3	.	.	PUNCT
dpc-4275	45	1	sollena	sollena	PROPN
dpc-4275	45	2	p	p	X
dpc-4275	45	3	,	,	PUNCT
dpc-4275	45	4	vasiliki	vasiliki	PROPN
dpc-4275	45	5	n	n	CCONJ
dpc-4275	45	6	,	,	PUNCT
dpc-4275	45	7	kotteas	kotteas	PROPN
dpc-4275	45	8	e	e	PROPN
dpc-4275	45	9	,	,	PUNCT
dpc-4275	45	10	et	et	PROPN
dpc-4275	45	11	al	al	PROPN
dpc-4275	45	12	.	.	PUNCT
dpc-4275	46	1	cyclin	cyclin	NOUN
dpc-4275	46	2	-	-	PUNCT
dpc-4275	46	3	dependent	dependent	ADJ
dpc-4275	46	4	kinase	kinase	NOUN
dpc-4275	46	5	4/6	4/6	NUM
dpc-4275	46	6	inhibitors	inhibitor	NOUN
dpc-4275	46	7	and	and	CCONJ
dpc-4275	46	8	dermatologic	dermatologic	ADJ
dpc-4275	46	9	adverse	adverse	ADJ
dpc-4275	46	10	events	event	NOUN
dpc-4275	46	11	:	:	PUNCT
dpc-4275	46	12	results	result	VERB
dpc-4275	46	13	from	from	ADP
dpc-4275	46	14	the	the	DET
dpc-4275	46	15	eadv	eadv	ADJ
dpc-4275	46	16	task	task	NOUN
dpc-4275	46	17	force	force	NOUN
dpc-4275	46	18	“	"	PUNCT
dpc-4275	46	19	dermatology	dermatology	NOUN
dpc-4275	46	20	for	for	ADP
dpc-4275	46	21	cancer	cancer	NOUN
dpc-4275	46	22	patients	patient	NOUN
dpc-4275	46	23	”	"	PUNCT
dpc-4275	46	24	international	international	ADJ
dpc-4275	46	25	study	study	NOUN
dpc-4275	46	26	.	.	PUNCT
dpc-4275	47	1	cancers	cancer	NOUN
dpc-4275	47	2	(	(	PUNCT
dpc-4275	47	3	basel	basel	PROPN
dpc-4275	47	4	)	)	PUNCT
dpc-4275	47	5	.	.	PUNCT
dpc-4275	48	1	2023	2023	NUM
dpc-4275	48	2	jul	jul	PROPN
dpc-4275	48	3	18;15(14):3658	18;15(14):3658	NUM
dpc-4275	48	4	.	.	PUNCT
dpc-4275	49	1	doi	doi	NOUN
dpc-4275	49	2	:	:	PUNCT
dpc-4275	49	3	10.3390	10.3390	NUM
dpc-4275	49	4	/	/	SYM
dpc-4275	49	5	cancers15143658	cancers15143658	PROPN
dpc-4275	49	6	.	.	PUNCT
dpc-4275	50	1	pmid	pmid	NOUN
dpc-4275	50	2	:	:	PUNCT
dpc-4275	50	3	37509319	37509319	NUM
dpc-4275	50	4	;	;	PUNCT
dpc-4275	50	5	pmcid	pmcid	ADJ
dpc-4275	50	6	:	:	PUNCT
dpc-4275	50	7	pmc10377938	pmc10377938	ADJ
dpc-4275	50	8	.	.	PUNCT
dpc-4275	51	1	2	2	X
dpc-4275	51	2	.	.	X
dpc-4275	51	3	fattore	fattore	NOUN
dpc-4275	51	4	d	d	NOUN
dpc-4275	51	5	,	,	PUNCT
dpc-4275	51	6	fabbrocini	fabbrocini	NOUN
dpc-4275	51	7	g	g	NOUN
dpc-4275	51	8	,	,	PUNCT
dpc-4275	51	9	sibaud	sibaud	NOUN
dpc-4275	51	10	v	v	NOUN
dpc-4275	51	11	,	,	PUNCT
dpc-4275	51	12	sollena	sollena	PROPN
dpc-4275	52	1	p.	p.	PROPN
dpc-4275	52	2	the	the	DET
dpc-4275	52	3	urgent	urgent	ADJ
dpc-4275	52	4	need	need	NOUN
dpc-4275	52	5	of	of	ADP
dpc-4275	52	6	dermatologists	dermatologist	NOUN
dpc-4275	52	7	for	for	ADP
dpc-4275	52	8	cancer	cancer	NOUN
dpc-4275	52	9	patients	patient	NOUN
dpc-4275	52	10	in	in	ADP
dpc-4275	52	11	italy	italy	PROPN
dpc-4275	52	12	.	.	PUNCT
dpc-4275	53	1	ital	ital	PROPN
dpc-4275	53	2	j	j	PROPN
dpc-4275	53	3	dermatol	dermatol	PROPN
dpc-4275	53	4	venerol	venerol	PROPN
dpc-4275	53	5	.	.	PUNCT
dpc-4275	54	1	2023	2023	NUM
dpc-4275	54	2	jun;158(3):274	jun;158(3):274	NOUN
dpc-4275	54	3	-	-	PUNCT
dpc-4275	54	4	275	275	NUM
dpc-4275	54	5	.	.	PUNCT
dpc-4275	55	1	doi	doi	NOUN
dpc-4275	55	2	:	:	PUNCT
dpc-4275	55	3	10.23736	10.23736	NUM
dpc-4275	55	4	/	/	SYM
dpc-4275	55	5	s2784	s2784	PROPN
dpc-4275	55	6	-	-	PUNCT
dpc-4275	55	7	8671.23	8671.23	NUM
dpc-4275	55	8	.07531	.07531	PROPN
dpc-4275	55	9	-	-	PUNCT
dpc-4275	55	10	x.	x.	PROPN
dpc-4275	55	11	epub	epub	PROPN
dpc-4275	55	12	2023	2023	NUM
dpc-4275	55	13	may	may	PROPN
dpc-4275	55	14	10	10	NUM
dpc-4275	55	15	.	.	PUNCT
dpc-4275	56	1	pmid	pmid	NOUN
dpc-4275	56	2	:	:	PUNCT
dpc-4275	56	3	37162245	37162245	NUM
dpc-4275	56	4	.	.	PUNCT
dpc-4275	57	1	3	3	X
dpc-4275	57	2	.	.	X
dpc-4275	57	3	searle	searle	PROPN
dpc-4275	57	4	t	t	PROPN
dpc-4275	57	5	,	,	PUNCT
dpc-4275	57	6	ali	ali	PROPN
dpc-4275	57	7	fr	fr	PROPN
dpc-4275	57	8	,	,	PUNCT
dpc-4275	57	9	al	al	PROPN
dpc-4275	57	10	-	-	PUNCT
dpc-4275	57	11	niaimi	niaimi	PROPN
dpc-4275	57	12	f.	f.	PROPN
dpc-4275	57	13	perioral	perioral	PROPN
dpc-4275	57	14	dermatitis	dermatitis	PROPN
dpc-4275	57	15	:	:	PUNCT
dpc-4275	57	16	diagnosis	diagnosis	NOUN
dpc-4275	57	17	,	,	PUNCT
dpc-4275	57	18	proposed	propose	VERB
dpc-4275	57	19	etiologies	etiology	NOUN
dpc-4275	57	20	,	,	PUNCT
dpc-4275	57	21	and	and	CCONJ
dpc-4275	57	22	management	management	NOUN
dpc-4275	57	23	.	.	PUNCT
dpc-4275	58	1	j	j	PROPN
dpc-4275	58	2	cosmet	cosmet	PROPN
dpc-4275	58	3	dermatol	dermatol	NOUN
dpc-4275	58	4	.	.	PUNCT
dpc-4275	59	1	2021	2021	NUM
dpc-4275	59	2	dec;20(12):3839	dec;20(12):3839	NOUN
dpc-4275	59	3	-	-	PUNCT
dpc-4275	59	4	3848	3848	NUM
dpc-4275	59	5	.	.	PUNCT
dpc-4275	60	1	doi	doi	NOUN
dpc-4275	60	2	:	:	PUNCT
dpc-4275	60	3	10.1111	10.1111	NUM
dpc-4275	60	4	/	/	SYM
dpc-4275	60	5	jocd.14060	jocd.14060	PROPN
dpc-4275	60	6	.	.	PUNCT
dpc-4275	61	1	epub	epub	PROPN
dpc-4275	61	2	2021	2021	NUM
dpc-4275	61	3	mar	mar	PROPN
dpc-4275	61	4	16	16	NUM
dpc-4275	61	5	.	.	PUNCT
dpc-4275	62	1	pmid	pmid	NOUN
dpc-4275	62	2	:	:	PUNCT
dpc-4275	62	3	33751778	33751778	NUM
dpc-4275	62	4	4	4	NUM
dpc-4275	62	5	.	.	PUNCT
dpc-4275	62	6	amigo	amigo	PROPN
dpc-4275	62	7	m	m	PROPN
dpc-4275	62	8	,	,	PUNCT
dpc-4275	62	9	hoffman	hoffman	PROPN
dpc-4275	62	10	k	k	PROPN
dpc-4275	62	11	,	,	PUNCT
dpc-4275	62	12	chung	chung	PROPN
dpc-4275	62	13	c	c	X
dpc-4275	62	14	,	,	PUNCT
dpc-4275	62	15	et	et	PROPN
dpc-4275	62	16	al	al	PROPN
dpc-4275	62	17	.	.	PROPN
dpc-4275	62	18	presentation	presentation	NOUN
dpc-4275	62	19	and	and	CCONJ
dpc-4275	62	20	management	management	NOUN
dpc-4275	62	21	of	of	ADP
dpc-4275	62	22	diverse	diverse	ADJ
dpc-4275	62	23	cutaneous	cutaneous	ADJ
dpc-4275	62	24	reactions	reaction	NOUN
dpc-4275	62	25	after	after	ADP
dpc-4275	62	26	cyclin	cyclin	NOUN
dpc-4275	62	27	-	-	PUNCT
dpc-4275	62	28	dependent	dependent	ADJ
dpc-4275	62	29	kinase	kinase	NOUN
dpc-4275	62	30	4/6	4/6	NUM
dpc-4275	62	31	inhibitor	inhibitor	NOUN
dpc-4275	62	32	use	use	NOUN
dpc-4275	62	33	.	.	PUNCT
dpc-4275	63	1	j	j	PROPN
dpc-4275	63	2	am	be	AUX
dpc-4275	63	3	acad	acad	ADJ
dpc-4275	63	4	dermatol	dermatol	NOUN
dpc-4275	63	5	.	.	PUNCT
dpc-4275	64	1	2022	2022	NUM
dpc-4275	64	2	jun;86(6	jun;86(6	ADP
dpc-4275	64	3	):	):	PUNCT
dpc-4275	64	4	1346	1346	NUM
dpc-4275	64	5	-	-	SYM
dpc-4275	64	6	1348	1348	NUM
dpc-4275	64	7	.	.	PUNCT
dpc-4275	65	1	doi	doi	NOUN
dpc-4275	65	2	:	:	PUNCT
dpc-4275	65	3	10.1016	10.1016	NUM
dpc-4275	65	4	/	/	SYM
dpc-4275	65	5	j.jaad.2021.04.092	j.jaad.2021.04.092	PROPN
dpc-4275	65	6	.	.	PUNCT
dpc-4275	66	1	epub	epub	NOUN
dpc-4275	66	2	2021	2021	NUM
dpc-4275	66	3	may	may	AUX
dpc-4275	66	4	 	 	SPACE
dpc-4275	66	5	5	5	NUM
dpc-4275	66	6	.	.	PUNCT
dpc-4275	67	1	pmid	pmid	NOUN
dpc-4275	67	2	:	:	PUNCT
dpc-4275	67	3	33961922	33961922	NUM
dpc-4275	67	4	.	.	PUNCT
dpc-4275	68	1	5	5	X
dpc-4275	68	2	.	.	X
dpc-4275	68	3	richey	richey	PROPN
dpc-4275	68	4	df	df	PROPN
dpc-4275	68	5	,	,	PUNCT
dpc-4275	68	6	hopson	hopson	PROPN
dpc-4275	68	7	b.	b.	PROPN
dpc-4275	68	8	photodynamic	photodynamic	PROPN
dpc-4275	68	9	therapy	therapy	NOUN
dpc-4275	68	10	for	for	ADP
dpc-4275	68	11	perioral	perioral	ADJ
dpc-4275	68	12	dermatitis	dermatitis	NOUN
dpc-4275	68	13	.	.	PUNCT
dpc-4275	69	1	j	j	PROPN
dpc-4275	69	2	drugs	drug	NOUN
dpc-4275	69	3	dermatol	dermatol	NOUN
dpc-4275	69	4	.	.	PUNCT
dpc-4275	70	1	2006	2006	NUM
dpc-4275	70	2	feb;5(2	feb;5(2	ADP
dpc-4275	70	3	suppl):12	suppl):12	PROPN
dpc-4275	70	4	-	-	PUNCT
dpc-4275	70	5	6	6	NUM
dpc-4275	70	6	.	.	PUNCT
dpc-4275	71	1	pmid	pmid	NOUN
dpc-4275	71	2	:	:	PUNCT
dpc-4275	71	3	16485876	16485876	NUM
dpc-4275	71	4	.	.	PUNCT
dpc-4275	72	1	figure	figure	NOUN
dpc-4275	72	2	1	1	NUM
dpc-4275	72	3	.	.	PUNCT
dpc-4275	72	4	first	first	ADJ
dpc-4275	72	5	visit	visit	NOUN
dpc-4275	72	6	of	of	ADP
dpc-4275	72	7	the	the	DET
dpc-4275	72	8	patient	patient	NOUN
dpc-4275	72	9	.	.	PUNCT
dpc-4275	73	1	the	the	DET
dpc-4275	73	2	patient	patient	NOUN
dpc-4275	73	3	in	in	ADP
dpc-4275	73	4	treatment	treatment	NOUN
dpc-4275	73	5	with	with	ADP
dpc-4275	73	6	palbociclib	palbociclib	NOUN
dpc-4275	73	7	presents	present	VERB
dpc-4275	73	8	diffuse	diffuse	VERB
dpc-4275	73	9	papules	papule	NOUN
dpc-4275	73	10	and	and	CCONJ
dpc-4275	73	11	rare	rare	ADJ
dpc-4275	73	12	pustules	pustule	NOUN
dpc-4275	73	13	around	around	ADP
dpc-4275	73	14	the	the	DET
dpc-4275	73	15	mouth	mouth	NOUN
dpc-4275	73	16	,	,	PUNCT
dpc-4275	73	17	the	the	DET
dpc-4275	73	18	nose	nose	NOUN
dpc-4275	73	19	,	,	PUNCT
dpc-4275	73	20	and	and	CCONJ
dpc-4275	73	21	the	the	DET
dpc-4275	73	22	orbits	orbit	NOUN
dpc-4275	73	23	,	,	PUNCT
dpc-4275	73	24	on	on	ADP
dpc-4275	73	25	an	an	DET
dpc-4275	73	26	erythematous	erythematous	ADJ
dpc-4275	73	27	background	background	NOUN
dpc-4275	73	28	.	.	PUNCT
dpc-4275	74	1	figure	figure	NOUN
dpc-4275	74	2	2	2	NUM
dpc-4275	74	3	.	.	PUNCT
dpc-4275	74	4	visit	visit	NOUN
dpc-4275	74	5	after	after	ADP
dpc-4275	74	6	three	three	NUM
dpc-4275	74	7	mal	mal	ADJ
dpc-4275	74	8	-	-	PUNCT
dpc-4275	74	9	pdt	pdt	NOUN
dpc-4275	74	10	sessions	session	NOUN
dpc-4275	74	11	:	:	PUNCT
dpc-4275	74	12	a	a	DET
dpc-4275	74	13	considerable	considerable	ADJ
dpc-4275	74	14	reduction	reduction	NOUN
dpc-4275	74	15	in	in	ADP
dpc-4275	74	16	the	the	DET
dpc-4275	74	17	number	number	NOUN
dpc-4275	74	18	of	of	ADP
dpc-4275	74	19	papules	papule	NOUN
dpc-4275	74	20	and	and	CCONJ
dpc-4275	74	21	in	in	ADP
dpc-4275	74	22	the	the	DET
dpc-4275	74	23	extension	extension	NOUN
dpc-4275	74	24	of	of	ADP
dpc-4275	74	25	the	the	DET
dpc-4275	74	26	erythematous	erythematous	ADJ
dpc-4275	74	27	area	area	NOUN
dpc-4275	74	28	from	from	ADP
dpc-4275	74	29	the	the	DET
dpc-4275	74	30	first	first	ADJ
dpc-4275	74	31	session	session	NOUN
dpc-4275	74	32	.	.	PUNCT